Inogen, Inc. INGN

Inogen has chosen make the divestiture amid declining revenues for the segment.

BEVERLY, Mass., September 30, 2026--INOGEN ANNOUNCES DIVESTITURE OF ITS U.S. OXYGEN RENTAL BUSINESS TO ROTECH

Stryker's sales have grown about 10% a year on average over the past three years, and so have ResMed's. That shared growth rate in medical devices is the bet the two have in common. Stryker (SYK) is the giant, selling hospitals everything from hip and knee products to capital equipment. ResMed is a sleep device maker with less than a quarter of Stryker's revenue. Stryker costs 32.6 times its past year's earnings, against 21.9 times for ResMed. So does Stryker's reach justify that higher price? T

INGN's POC demand, new products and international growth support its outlook, while U.S. channel shifts and distributor timing pose risks.

On August 6, Inogen (NASDAQ:INGN) reported second-quarter results that captured the company’s split personality right now. International sales keep compounding, new products are finding buyers, and profitability is improving. But the US business is still losing ground to a structural shift in how patients get oxygen therapy, and that weakness was enough to push full-year […]

Moby summary of Inogen, Inc.'s Q2 2026 earnings call

Despite lowering full-year revenue guidance, Inogen raises adjusted EBITDA outlook on robust international sales and successful new product launches.

Inogen (INGN) delivered earnings and revenue surprises of +17.65% and +0.30%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

BEVERLY, Mass., August 06, 2026--Reported second quarter revenue of $95.1 million. Company raises full-year adjusted EBITDA guidance to approximately $4.0 million

MKS Instruments director and former AWS executive to expand AI infrastructure firm’s stewardshipSAN FRANCISCO, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Smartbird, Inc. (NASDAQ: BIRD), an AI infrastructure provider, today announced the nomination of Elizabeth Mora and Dan Kasun for election to its board of directors at the company’s next annual meeting of stockholders. Mora is an experienced board director and finance executive with a strong governance background. She previously served as chief financia

BEVERLY, Mass., July 16, 2026--Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026

BEVERLY, Mass., July 01, 2026--Inogen Announces the Appointment of Andy Reding as Chief Operating Officer